Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Hargraves MM , Richmond H , Morton R . Presentation of two bone marrow elements: the ‘Tart’ cell and the ‘LE’ cell . Proc Staff Mayo Clinic 1948; 23: 25-28 .

Haserick JR , Lewis LA , Bortz DW . Blood factor in acute disseminated lupus erythematosus: determination of gamma globulin as specific plasma fraction . Am J Med Sci 1950; 219: 660-663 .

Marmont AM . Beobachtungen uber das sogenannte L.E.-Pha Schweiz Med Wschr 1952; 82: 1111-1113 .

Marmont AM . The transfusion of active LE plasma into nonlupus recipients, with a note on the LE-like cell . Ann NY Acad Sci 1965; 124: 838-851 .

Alarcón-Segovia D. Antinuclear antibodies: to penetrate or not to penetrate, that was the question . Lupus 2001; 10: 315-318 .

Hiepe F , Dörner T , Burmester G-R (eds). Antinuclear antibodies . Int Arch Allergy Immunol 2000; 123: 5-97 .

Marmont AM , Damasio EE , Bacigalupo A et al. A to O bone marrow transplantation in severe aplastic anemia: dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow . Br J Haematol 1977; 36: 511-514 .

Denman AM , Russell AS , Denman EJ . Adoptive transfer of the diseases of New Zealand Black mice to normal mouse strains . Clin ExpImmunol 1969; 5: 269-273 .

Morton JL , Siegel BV . Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice . Proc Natl Acad Sci USA 1974; 71: 2162-2166 .

10.

Van Bekkum DW . Stem cell transplantation in experimental models of autoimmune disease . J Clin Immunol 2000; 20: 10-16 .

11.

Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation . ExpHematol 2001; 29: 661-669 .

12.

Akizuki M , Reeves JP , Steinberg AD . Expression of autoimmunity by NZB/NZW marrow . Clin Immunol Immunopathol 1978; 10: 247-250 .

13.

Reininger L , Radskiewicz T , Kosco F . Development of autoimmune disease in SCID micepopulated with long-term ‘in vitro’ proliferating (NZB NZW) F1 pre-B cells . J ExpMed 1992; 176: 1343-1353 .

14.

Blank M , Krause J , Lanir N et al. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell . Arthritis Rheum 1995; 38: 115-122 .

15.

Kushida T , Inaba M , Hisha H et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice . Blood 2001; 97: 3292-3298 .

16.

Knaan-Shanzer S , Houben P , Kinwel-Bohré EBM , van Bekkum DW . Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation . Bone Marrow Transplant 1992; 8: 333-338 .

17.

Van Gelder M , van Bekkum DW . Effective treatment of relapsing autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation . Bone Marrow Transplant 1996; 18: 1029-1034 .

18.

Sondel PM . The graft-versus-leukemia effect. In: Barrett J , Jiang Y-Z (eds). Allogeneic Immunotherapy for Malignant Disease. Dekker: New York , 2000, pp 1-12.

19.

Slavin S , Nagler A , Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disease . Blood 1998; 91: 756-763 .

20.

Appelbaum FR . Hematopoietic cell transplantation as immunotherapy . Nature 2001; 411: 385-389 .

21.

Li H , Kaufman CL , Boggs SS et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice . J Immunol 1996; 156: 380-387 .

22.

Jeung E , Iwakosh N , Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD 154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in isletallografted NOD/Lt mice . Blood 2000; 95: 2175-2182 .

23.

McSweeney PA , Niederwieser D , Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects . Blood 2001; 97: 3390-3400 .

24.

Barrett J , Jiang Y-Z (eds). Allogeneic immunotherapy for Malignant Disease. Dekker: New York , 2000, pp 1-386.

25.

Tyndall A , Williken S . Bone marrow transplantation . Baillére's Clin Rheumatol 1999; 13: 719-755 .

26.

Lowenthal RM , Graham SR . Does haemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis? J Clin Immunol 2000; 1: 17-23 .

27.

McSweeney PA , Furst DE , West SG . High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions . (Editorial.) Arthritis Rheum 1999; 42: 2269-2274 .

28.

Lopez Cubero SO , Sullivan KM , McDonald GB . Course of Crohn's disease after allogeneic bone marrow transplantation: report of 6 cases . Gastroenterology 1998; 114: 433-440 .

29.

McKendry RJR , Huebsch L , Le Clair B . Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13-year follow-up . Arthritis Rheum 1996; 39: 1246-1253 .

30.

Slavin S. Treatment of life-threatening autoimmune disease with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT . Bone Marrow Transplant 1993; 12: 201-210 .

31.

Tyndall A , Fassas A , Passweg J et al. Autologous hematopoietic stem cell transplantation for autoimmune disease—feasibility and transplant-related mortality . Bone Marrow Transplant 1999; 24: 729-734 .

32.

Nash RA . Prospects of stem cell transplantation in autoimmune diseases . J Clin Immunol 2000; 20: 38-45 .

33.

Snowden JA , Brooks PM , Biggs JC . Haematopoietic stem cell transplantation for autoimmune diseases . Br J Haematol 1997; 99: 9-22 .

34.

Burt RK , Traynor A . Hematopoietic stem cell therapy of autoimmune diseases . Curr Opin Hematol 1998; 5: 472-477 .

35.

Marmont AM . New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation . A Rev Med 2000; 51: 115-134 .

36.

Marmont AM . Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems . Haematologica 2001; 86: 337-345 .

37.

Brodsky R , Sensenbrenner LL , Jones RJ . Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide . Blood 1996; 87: 491-494 .

38.

Brodsky R , Petri M , Smith ED et al. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease . Ann Intern Med 1998; 129: 1031-1035 .

39.

Brodsky R , Petri M , Jones JJ . Hematopoietic stem cell transplantation for systemic lupus erythematosus . Rheum Dis Clin N Am 2000; 26: 377-387 .

40.

Khamashta M , Hughes G (eds). Accelerated atheroma—leads from lupus . Lupus 2000; 9: 159-231 .

41.

Marmont AM . Perspective: immunoablation with stem cell rescue: a possible cure for systemic lupus erythematosus . Lupus 1993; 2: 151-156 .

42.

Marmont AM , van Lint MT , Gualandi F , Bacigalupo A . Autologous marrow stem cell transplantation for systemic lupus erythematosus of long duration . Lupus 1997; 2: 151-156 .

43.

Burt RK , Traynor AE , Ramsey-Goldman R . Hematopoietic stem cell transplantation for systemic lupus erythematosus. (Letter.) New Engl J Med 1997; 357: 1777-1778 .

44.

Musso M , Porretto F , Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome . Lupus 1998; 7: 492-494 .

45.

Musso M , Porretto F , Crescimanno A et al. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell infusion for severe autoimmune diseases . Am J Hematol 2001; 66: 75-79 .

46.

Fouillard L , Gorin NC , Laporte JPh et al. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cell from peripheral blood . Lupus 1999; 8: 320-323 .

47.

Traynor AE , Schroeder J , Rosa RM et al. Treatment of severe systemic lupus erythematosus with high dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study . Lancet 2000; 356: 701-707 .

48.

Binks M , Passweg JR , Furst D et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure-related mortality and impact on skin disease . Ann Rheum Dis 2001; 60: 577-584 .

49.

Alarcon-Segovia D , Alarcon-Riquelme ME . Etiopathogenesis of systemic lupus erythematosus: a tale of three troikas. In Lahita RG (ed). Systemic Lupus Erythematosus. Academic Press: San Diego, CA , 1999, pp 55-65.

50.

Liossis S-N , Tsokos GC . Pathogenesis of rheumatic diseases. Systemic lupus erythematosus. In: Tsokos GC (ed). Principles of Molecular Rheumatologic. Humana Press: Totowa, NJ , 2000, pp 311-323.

51.

Feist E, Dorner T, Kuckelkorn U et al. Diagnostic importance of anti-proteasome antibodies . Int Arch Allergy Immunol 2000; 23: 92-97 .

52.

Rosen A, Casciola-Rosen L. Clearing the way to mechanisms of autoimmunity . Nature Med 2001; 7: 664-665 .

53.

Verburg RJ, Kruize AA, van den Hoogen FHJ et al. High dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis . Arthritis Rheum 2001; 44: 754-760 .

54.

Van Laar JM. Immune ablation and stem-cell therapy in autoimmune disease: immunological reconstitution after high-dose immunosuppression and hematopoietic stem-cell transplantation . Arthritis Res 2000; 2: 270-275 .

55.

Burt RK , Brenner M , Burns W et al. Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease . J Clin Immunol 2000; 20: 1-9 .

56.

Donek DC , Vescio RA , Betts MR et al. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution . Lancet 2000; 355: 1875-1881 .

57.

Horowitz DA . Peripheral blood CD4+ T cells in systemic lupus erythematosus . (Editorial.) Lupus 2001; 10: 319-320 .

58.

Kashyap A , Passweg J , Tyndall A . Autologous hematopoietic stem cell transplantation conditioning regimens for the treatment of severe autoimmune disease. In: Dicke KA , Keating A (eds). Autologous Blood and Marrow Transplantation. Carden Jennings: Charlottesville , 2001, pp 219-225.

59.

Reiffers J , Caillot C , Dazey B et al. Abrogation of postmyeloablative chemotherapy neutropenia by ex vivo expanded autologous CD 34-positive cells . Lancet 1999; 354: 1092-1093 .

60.

McNiece I , Briddell R . Ex vivo expansion of hematopoietic progenitor cells and mature cells . ExpHematol 2001; 29: 3-11 .

61.

Marmont AM . Immunoablation followed or not by hematopoietic stem cell infusion as an intense therapy for severe autoimmune diseases: new perspectives, new problems. In: Dicke KA , Keating A (eds). Autologous Blood and Marrow Transplantation. Carden Jennings: Charlottesville , 2001, pp 183-202.

Lupus: tinkering with haematopoietic stem cells

Abstract

Get full access to this article

References